Form 4: NeueHealth Executive Michael Craig Awarded Restricted Stock Units Following Shareholder Approval

Sentiment:

SEC Form 4 Filing


NeueHealth's General Counsel and Corporate Secretary, Michael Craig, received grants of restricted stock units after shareholder approval of an amendment to the company's incentive plan.

Summary

  • Michael Craig, General Counsel & Corporate Secretary of NeueHealth, Inc., was granted restricted stock units (RSUs) on May 2, 2024.
  • The grants were contingent upon shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which was obtained on May 2, 2024.
  • One grant consists of 42,000 RSUs, vesting in three equal annual installments beginning on March 11, 2025.
  • The other grant consists of 100,000 RSUs, vesting 100% on October 11, 2026.
  • Each RSU represents a contingent right to receive one share of NeueHealth's common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the executive and the company's future. The shareholder approval is also a positive sign.

Positives

  • The grants of RSUs to a key executive like Michael Craig can serve as an incentive for continued service and performance.
  • The vesting schedules (March 11, 2025, and October 11, 2026) encourage long-term commitment from the executive.
  • Shareholder approval of the incentive plan amendment suggests support for the company's compensation strategy.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs.

Industry Context

Granting RSUs to executives is a common practice in the healthcare industry to align management's interests with those of shareholders and incentivize long-term growth.

Comparison to Industry Standards

  • RSU grants are a standard component of executive compensation packages in publicly traded companies, including those in the healthcare sector.
  • Companies like UnitedHealth Group and CVS Health also utilize equity-based compensation to incentivize their executives.
  • The vesting schedules (3-year graded vesting and cliff vesting) are also common structures observed in similar companies.

Stakeholder Impact

  • Shareholders may view the RSU grants positively as they align executive interests with long-term company performance.
  • Employees may see the grants as a sign of the company's commitment to its leadership team.

Key Dates

DateDescription
March 11, 2024Date the 42,000 RSU grant was approved by the Issuer's Compensation and Human Capital Committee.
October 11, 2023Date the 100,000 RSU grant was approved by the Issuer's Compensation and Human Capital Committee.
May 02, 2024Date of the transaction and shareholder approval of the amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan.
March 11, 2025First vesting date for the 42,000 RSU grant (one-third vests).
October 11, 2026Vesting date for 100% of the 100,000 RSU grant.
May 06, 2024Date of the form filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.